article thumbnail

World Psoriasis Day 2024: New Treatments and Research Trends

XTalks

Trends in Psoriasis Research: Biologics, Biosimilars and New Therapies Recent innovations in biologics and biosimilars have transformed psoriasis care. Trends in Psoriasis Research: Biologics, Biosimilars and New Therapies Recent innovations in biologics and biosimilars have transformed psoriasis care.

Research 105
article thumbnail

Almirall announces a new research collaboration with the University of Dundee to develop an innovative and differentiated treatment approach for dermatological diseases

Pharma Mirror

BARCELONA, Spain and Dundee, UK, a global biopharmaceutical company focused on skin health, today announced a research collaboration with the University of Dundee, a top-ranked university in the UK in biological sciences, to develop a novel approach against chronic and debilitating dermatology diseases where itch, or pruritus, plays a dominant role.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Strong solutions for increasing dermatology research diversity: Trust me, I’ve got skin in the game

pharmaphorum

Strong solutions for increasing dermatology research diversity: Trust me, I’ve got skin in the game Mike.Hammerton Fri, 11/08/2023 - 08:00 Bookmark this

article thumbnail

Journey Medical’s Emrosi Wins FDA Approval for Rosacea, Could Rival Galderma’s Oracea

XTalks

Research suggests that certain bacteria, particularly those associated with Demodex mites (tiny mites that naturally live on human skin) like Bacillus oleronius , could contribute to rosacea in some individuals. Journey Medical plans to make Emrosi available by early 2025 through dermatology clinics and pharmacies across the US.

article thumbnail

Fishawack Health welcomes expert-led dermatology initiative FIDE to its group

pharmaphorum

KNUTSFORD, United Kingdom — Fishawack Health welcomes FIDE, an independent organization providing its clients with insight from clinical key opinion leaders in inflammatory dermatology. FIDE’s global healthcare experts provide biopharmaceutical companies with unique insights from early phase research to real-world evidence post-approval.

article thumbnail

Dermatology program brings timely and accurate diagnosis of skin conditions to underserved communities

Medical Xpress

A dermatology program first developed by the University of Missouri in 2015 can bring life-saving diagnoses of skin conditions to communities without adequate dermatologic care.

article thumbnail

Almirall and IRB Barcelona announce a research collaboration to discover novel molecular glue therapeutics for severe skin diseases

Pharma Mirror

The collaboration brings together Almirall’s scientific, dermatological, and data analysis knowledge with the expertise of the IRB Barcelona’s Targeted. The post Almirall and IRB Barcelona announce a research collaboration to discover novel molecular glue therapeutics for severe skin diseases appeared first on Pharma Mirror Magazine.

Research 130